neurgain

Neurgain Chronic back pain (traumatic and neuropathic) affects over 26 million Americans, of which about 7 million have spinal stiffness (spasticity). Current therapeutic management is not working: drugs in use have poor efficacy, and cause undesirable side effects such as resistance, dependency/abuse and other disorders. The estimated annual economic burden of back pain is over […] The post Neurgain appeared first on Business RadioX ®.